“…Although germline p16 INK4 (and p19 ARF ) mutations are present in some families with hereditary melanoma, p16 INK4 mutations are uncommon in sporadic melanoma, and while this gene may be inactivated via another mechanism (such as methylation or homozygous deletion) there is still some debate as to whether this is the sole target of 9p loss or whether there are additional relevant tumour suppressor genes on 9p (Fountain et al, 1992;Holland et al, 1994;Hussussian et al, 1994;Kamb et al, 1994;Ohta et al, 1994;Gruis et al, 1995a,b;Merlo et al, 1995;Puig et al, 1995;Quelle et al, 1995;Flores et al, 1996;Healy et al, 1996b;Kim et al, 1997;Wiest et al, 1997). Candidate tumour suppressor genes on 6q and 10q include AIM1 and PTEN/MMAC1 respectively, however, whether these genes are inactivated during primary cutaneous melanoma development and progression is unclear at present (Ray et al, 1997;Li et al, 1997;Steck et al, 1997).…”